NCT00170053View on ClinicalTrials.gov

Comparison of Sirolimus to Tacrolimus for Long Term Therapy in Kidney Transplant With no Steroids

PHASE1CompletedINTERVENTIONAL
Enrollment

177

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Kidney Diseases
Interventions
DRUG

Sirolimus

10 mg oral loading dose followed by 5 mg/day. Measure Sirolimus level weekly and adjust to level of 10-15 ng/ml.

Trial Locations (1)

32224

Mayo Clinic, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

collaborator

Genzyme, a Sanofi Company

INDUSTRY

collaborator

Raymond Heilman

UNKNOWN

lead

Mayo Clinic

OTHER